Author Login

Correspondence to Author: Antni Frano, Atony A. Pelegino,, Coimo De uzio,Mogan Sakowsk,Jmal C. Jakson,Lcas B. Zkowsi,Erico Cecucci,Srinivas Vorgat,Aexader K. Ch0,Fraceco Popigla,Jad Kaok,Sione Crvelar,Ricardo Auorin.  

University of North Carolina Health, Chapel Hill, NC

Abstract:

The US Food and Drug Administration authorized the da Vinci Single Port (SP) robotic system for use in urologic treatments in 2018. There aren’t many research on the use of SP in prostate cancer surgery. Our study’s objective is to compile the most recent data regarding the methods The results of surgeries involving SP robot-assisted radical prostatectomy (SP-RARLP). In January 2023, a narrative evaluation of the literature was conducted. According to preliminary findings, SP-RALP is both possible and safe, and it can produce results that are on par with those of the conventional multiport RALP.Given their reduced invasiveness, likely shorter duration of stay, and improved pain management, extraperitoneal and transvesical SP-RALP seem to be the two most promising strategies. Long-term, superior data are lacking, and additional verification through prospective research at several locations is necessary.

Keywords:single port; radical prostatectomy; robotic surgery; extraperitoneal

Citation:

Dr.Antni Frano, Where Are We Now With Single-Port Robot-Assisted Radical Prostatectomy?. Advances in Robotic Surgery 2025.